chrisvoncsefalvay/vaers-outcomes huggingface dataset:
bumps on inside of arms, back of legs and on stomach; This spontaneous case was reported by a consumer and describes the occurrence of RASH (bumps on inside of arms, back of legs and on stomach) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced RASH (bumps on inside of arms, back of legs and on stomach). At the time of the report, RASH (bumps on inside of arms, back of legs and on stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Dx: severe brachial plexopathy due to shingles. 12/10/07 came in with pain left neck - shoulder, hypersensitive skin, 3 small vesicles/erythema rash (L) neck. Pain and paresthesias progressed - LUE - neuropathy (L) brachial plexus with sensory and motor involvement. Slowly improving with phys therapy, gabapentin, analgesics.  4/4/08 Reviewed clinic records of 5/2007-3/2008. FINAL DX: severe left brachial plexopathy, likely secondary to herpes zoster infection, improving. Records reveal patient experienced good general health on 8/24/07.  Neck, hip & back pain 11-12/07 x 5 days & felt to be shingles.  Developed numbness, tingling, burning, shooting pain in shoulder, upper back, down left arm from neck.  Pain interferred w/sleep & was sleeping in chair.  Also has numbness left arm/hand & decreased ROM.  No improvement w/meds.  Dx w/sensory & motor neuropathy of LUE.  MRI & referred to neuro.  Neuro exam revealed left arm weakness w/significantly diminished strength in biceps, deltoid & grip.  Left arm muscle atrophy noted. Referred to PT & started neurontin.  Improved as of last note 3/11/08. Follow-up: Continues with some muscle weakness b/t shoulder girdle mild paresthesia. No pain. Has been able to D/C NEURONTON.
This spontaneous report as received from a consumer refers to approximately 27 year old female patient. Patient was not pregnant. Patient was allergic to antibiotics containing cephalosporin (manufacturer unknown). In July 2013, the patient was vaccinated with 3rd dose of GARDASIL, intramuscular. Concomitant therapies included ZOVIA. Patient received a recall letter from her physician which stated that she received the recalled lot (J007354) of GARDASIL, the recalled lot of GARDASIL was distributed between 20-AUG-2013 and 09-OCT-2013, therefore it was unkonwn how the patient would have received it, considering she reported she received her last dose sometime in July 2013. On an unknown date, after receiving GARDASIL the patient experienced shingles, patient stated that she do not know whether she developed shingles after first dose or second dose of GARDASIL. The patient was prescribed an antiviral medication (unspecified name, dose/frequency, and manufacturer), but it did not work. The outcome of the event was reported as recovering. Patient sought medical attention by visiting the office on an unknown date. No product quality issue was reported. Additional information has been requested.
Fever to 102.0; Mother gave antipyretics twice during the night. At clinic visit at 2:00pm fever was 105.3 rectally. Fever management, Pedialyte, blood work.
Large welt from injection lasting more than 3 weeks. Size and pain is reducing, but still has obvious presence.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 19-FEB-2018, the patient was vaccinated with an improperly stored dose of PROQUAD (recombinant Human albumin) (strength and route were unknown) (lot# M044718 and expiration date 07-MAY-2018) for prophylaxis (Incorrect product storage). The Merck Sterile Diluent was properly stored. No adverse event was reported. The excursion temperature on 22-SEP-2017, 17-OCT-2017, 06-DEC-2017, 07-DEC-2017, 30-JAN-2018, 23-FEB-2018, 18-MAY-2018, 05-JUL-2018, 15-AUG-2018 was 6 degree Celsius for maximize 8.75 hours. The excursion temperature on 02-MAR-2018, 27-AUG-2018 was 7 degree Celsius for maximize 8.75 hours. The excursion temperature on 07-DEC-2017 was 8 degree Celsius for maximize 15 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1809USA003709; US-009507513-1810USA001951; US-009507513-1810USA001952; US-009507513-1810USA001953; US-009507513-1810USA001954; US-009507513-1810USA001955; US-009507513-1810USA001956; US-009507513-1810USA001957; US-009507513-1810USA001959.
TEMP 100 08-25-08 NIGHT,7:30AM 08-26-08 101.4,@8:50AM 102.2.C/O LEG PAIN(STARTED 08-25-08 NIGHT)
I went to the emergency room for unexplained bruising. They found my platelet count was low. They spoke to a Hematologist. She confirmed my platelets were low and performed a complete CBC panel. She diagnosed me with Thrombocytopenia. I had a follow-up with the Hematologist the following Monday. She performed more blood work. My platelets were a little higher. She sent me home with a prescription for iron. I have to her again in a month.
Left deltoid not to touch 98 mm x 78 mm erythema , painful to touch.
I had severe headaches brought on by exercise and sex. They were localized on one side of my head and would come on suddenly debilitating. This happened about 4-5 times over the course of a few weeks, then went away.
Child inadvertently received 1st Pfizer COVID-19 vaccine approximately 60 days before her 12th birthday.  Per administering nurse:  "Family of 5 arrived as walk-ins to vaccine clinic at 1600.  The adult male was the only person that spoke language, the remaining spoke and understood only a different language.  The child and an adult female were the only 2 to request vaccinations.  The family struggled with filling out the required paperwork necessary for the vaccine.  Simultaneously other patients arrived for vaccinations, and clinic was busy.  Nurse brought family into clinic and explained all information about Pfizer vaccine while adult male interpreted.  The female child appeared older than her age and did not appear to be 12 years old.  I vaccinated both child and adult woman, observe them for 15 minutes afterwards, and they left without incident.  No signs/symptoms of adverse reaction identified for either person.  Language barrier was definitely an issue and distracted staff from normal procedure."   Family was notified that child was given vaccination earlier than approved by CDC and will not be able to receive second dose until on or after her 12th birthday.  Family verbalized understanding of this information.
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided. On 09-OCT-2018, the patient was vaccinated with ROTATEQ, lot # N005618, expiration date 04-OCT-2018 (dose, frequency was not reported) for prophylaxis. On 09-OCT-2018, the patient experienced expired product administered. No adverse effects reported.
Site: Pain at Injection Site-Mild, Additional Details: pt states has developed mouth sores that are very painful. Her gum line is also bleeding. swelling and sores have worsened since getting the vaccine on  11/5 and pt to call her provider today if an on call available or going to the urgent care.
After we left the Doctor office from getting a physical, took patient to school recieved a call from the school saying she was really shaking, patient also was dizzy, complained at ER that her chest was hurting, and she had a bad headache.
Severe headache; Chills; Fever (fever dropped after 2 days); Nausea; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 02Apr2021 at 14:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included appendectomy. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 12Mar2021 at 14:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 03Apr2021 at 03:00, the patient experienced severe headache, chills, fever and nausea which lasted about 4-5 days (fever dropped after 2 days). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache, chills, fever (fever dropped after 2 days) and nausea was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
12 hours after shots patient lost control of his body. He collapsed to floor and could not get up. This lasted 14 hours. This was accompanied by chills and vomiting.
This case was reported by a physician and described the occurrence of laceration of finger in a adult female patient who received ROTARIX (batch number A41CB548A, expiry date 28th February 2015) and (batch number A41CB528A, expiry date 28th February 2017). This case was associated with a product complaint. On an unknown date, the patient received ROTARIX. On an unknown date, the dose was an unknown dose. On an unknown date, immediately after receiving ROTARIX, the patient experienced laceration of finger and pharmaceutical product complaint. On an unknown date, the outcome of the laceration of finger and pharmaceutical product complaint were unknown. It was unknown if the reporter considered the laceration of finger to be related to ROTARIX. Additional details provided were as follows: The reporter stated that, a nurse had reconstituted the ROTARIX vaccine and while preparing to administer the vaccine, she cut her finger. The nurse stated that the glass under the plunger collar appeared broken. They did not administer the vaccine to the patient because fear of glass being in the vaccine. They set the vaccine aside for returning it to the GlaxoSmithKline.
Pt reports the development of patchy areas around his chin where hair was not growing back since his anthrax shot of Dec2004/Jan05. Pt noticed his beard hair problem since mid Feb 2005. Pt also described the development of recurring right outer lower or upper lip swelling and tingling for the past several months. No sore throat or painful swallowing reported. Alopecia (hair loss) Start: 02/2005 End: 11/2005.
Pt states 7 days after receiving the vaccine, her arm is red, itchy, hot, and swollen at site of injection. States the area where she had the injection is slightly raised. Symptoms didn't start until 7 days after receiving vaccine - states the only symptoms she had in the immediate few days after getting the vaccine was a sore arm. Denied SOB or hives elsewhere on body. RN advised Benadryl PO.
I did not have an adverse reaction to the vaccine. I was exposed to COVID-19 while on vacation. I tested positive for COVID-19 on 03/21/2023. I felt like it was a lingering cold. I contacted my doctor and got a prescription for Paxlovid.  I tolerated the medication without any complications.
After she had flu shot, she had pain on arm, neck, head and her eyelids were swollen (Friday afternoon) she had headache and all joints were aching. She took ALEVE for pain and it took whole 2 days to recover (Sunday afternoon).
This spontaneous report was received from a State Immunization Official and refers to a multiple patients (exact number unspecified) of unknown age and gender. The patients' concurrent conditions, drug reactions or allergies, concomitant therapies and medical histories were not provided. On multiple unspecified dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 injection, lot # L043214, 30-AUG-2017 and lot # M028323, 26-SEP-2018 (doses and routes of administration were not reported) for prophylaxis. Administered doses of vaccines experienced the temperature excursion of 29.3 degrees Fahrenheit (F) for 2 hours 56 minutes, 28.8 F for 7 hours 6 minutes, 34.7 F for 26 minutes, 34.5 F for 27 minutes, 33.6 F for 1 hour 13 minutes, 30.6 F for 5 hours 55 minutes, 31 F for 3 hours 30 minutes, 33 F for 1 hour 59 minutes, 33.4 F for 2 hours 20 minutes, 32 F for 4 hours 15 minutes, 32 F for 3 hours 52 minutes, 32 F for 4 hours 4 minutes, 30.1 F for 4 hours 53 minutes, 31.7 F for 4 hours 5 minutes, 32.5 F for 2 hours 21 minutes, 33.2 F for 2 hours 16 minutes and 33 F for 1 hour 23 minutes. Data logger was involved. There were no previous excursions reported. There was no adverse effect reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA014170: US-009507513-1612USA014168: US-009507513-1612USA014169.
fever, cough, loss of smell and taste, lots of miucus, cough feels like a tickle in throat. starting on 9/25/21
Generalized red macular rash most prominent on thighs and arms accompanied by generalized itching, starting approximately 36 hours after dose. No treatment given. Rash and itching improved as of 60 yours post dose.
Expired Vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was provided. No treatment medication details was provided.  The vaccine was administered after 15 days of first puncture.   This case was linked to MOD-2021-333740 (Patient Link).
sore arms; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arms). At the time of the report, PAIN IN EXTREMITY (sore arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided by the reporter.    Reporter did not allow further contact
Initial report received on 30 April 2008, and 01 May 2008 from a physician. It was reported a 40-year-old female patient (date of birth reported as 28 August 2007) who had a recent "staph" infection, and who has past medical history of "spring" allergies, allergy to "PCN" (Penicillin) and Keflex, and a history of eczema and allergic rhinitis, had received an intramuscular injection of ADACEL (Lot # C2888AA) on either 16 or 17 April 2008. The site of administration was "unknown." Per the reporter, it was "unknown" if any other vaccinations were received on the same day. Within 24 hours after receiving the ADACEL vaccination, the patient complained of arm pain, and developed generalized pruritus, angioedema, and was wheezing. Reportedly, the patient was evaluated by a physician and treated with Benadryl. At the time of this report, the patient had recovered.
BEEN EXPERIENCING LINGERING HEADACHES, JOINT SWELLING AND PAIN ESP. IN HANDS AND KNEES,  FATIGUE MORE THEN USUAL, DEEP COUGH ON AND OFF, AND LIGHT HEADED/OFF BALANCE.  NAIL BEDS ARE SWOLLEN IN HANDS AND FEET.
This spontaneous report was received from a pharmacist concerning a patient of unknown age and gender who on 03-APR-2013 was vaccinated with a dose of ZOSTAVAX that had expired on 02-apr-2013 (lot number not provided). No adverse effects had been reported. Additional information has been requested.
2/19/2023 I had been exposed to COVID. I was not feeling very well. I had mild symptoms. I had a scratchy throat and was a little feverish. The next day I felt tired, feverish and chest congestion. I took an at home COVID test that was positive. I had a telehealth on the 2/21/2023. She decided not to give me PAXLOVID since it was so mild. By 2/27/2023, I was symptom free, but still had chest congestion. My oxygen levels are n the low 90's. Everything else is fine.
feeling tired.; This is a spontaneous report from a Pfizer-sponsored program. A non-contactable female consumer (patient, self-reported).   A female unspecified age received the first dose of dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown), via an unspecified route of administration, on 27Jan2021, as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient did take a nap due to feeling tired, she had never called before. The patient stated that she was fine after the vaccination. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
After approximately 3 weeks I began to feel abdomen pain.  I went to sleep with the dull pain. The next morning I felt terrible. No appetite, fluctuating body temperature and dull abdomen pain. My appendix was about to go. I received an appendectomy.
This spontaneous report was received from a Registered Nurse referring to a patient of unknown age and gender. No concurrent or historical condition was reported. On an unspecified date in 1999 the patient was vaccinated with the first dose of (Oka/Merck) VARIVAX, lot number, expiration date, dose, route, and anatomical location were not reported. No concomitant therapy was reported. On an unknown date (also reported as shortly after the (Oka/Merck) VARIVAX was administered) the patient developed hives. The duration of the hives was not specified by the reporter. Additional information has been requested.
headache, sore throat, cough, nonproductive cough, fever, body aches, loss of smell, diarrhea, nasal congestion, chest congestion, itchy eyes. starting 12/2/21
clinic called 5/19/21 and asked if our immunization was administered on 5/12/21 or not because it wasn't showing in the MIIC. Verified that it was administered (Janssen) and input into MIIC. He also received dose one of Pfizer 2/5/21 and dose two of Pfizer 3/3/21 from other institution which was not caught. Tried calling patient, left voicemail.
Swelling and erythema at injection site Prevnar. Vomiting started after 4 hours, lasted 6 hours, 2 diarrhea stools. Asymptomatic in 36 hours.
Chills; Body ache; Fever; Horseness in voice; Rash on the arm; A little swelling on the arm; Feels as if had  a cold; Congestion and runny nose; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PAIN (Body ache), PYREXIA (Fever), DYSPHONIA (Horseness in voice) and RASH (Rash on the arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced CHILLS (Chills), PAIN (Body ache), PYREXIA (Fever), DYSPHONIA (Horseness in voice), RASH (Rash on the arm), PERIPHERAL SWELLING (A little swelling on the arm), NASOPHARYNGITIS (Feels as if had  a cold), NASAL CONGESTION (Congestion and runny nose) and RHINORRHOEA (Runny nose). At the time of the report, CHILLS (Chills), PAIN (Body ache), PYREXIA (Fever), DYSPHONIA (Horseness in voice), RASH (Rash on the arm), PERIPHERAL SWELLING (A little swelling on the arm), NASOPHARYNGITIS (Feels as if had  a cold), NASAL CONGESTION (Congestion and runny nose) and RHINORRHOEA (Runny nose) outcome was unknown.            Concomitant products were not provided/unknown. Treatment medication were not reported/unknown.   This case was linked to MOD-2021-023378 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow-up received as TCR on 11/5/21. Follow-up contains no new information.
Per nurse and father, patient became tonic(stiff) after vaccines for < 30 seconds. No clonic activity. Alert during and after.
pt recv vax 21OCT98 & 1NOV98 mom noticed couple raised spots on trunk;no fever, no irritability;no crusting more spots on 9NOV98 on trunk only;saw MD 13NOV98 for rash dx chickenpox;
administration of expired Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine) in a 90-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.   No treatment was given to the patient.   The vaccines were stored in freezer, were taken out one to two vials and placed in fridge each day as needed.
This spontaneous report as received from a pharmacist refers to multiple unspecified patients of unknown age and gender. Patients pertinent medical history, concurrent condition and concomitant medication were not reported. No previous drug reactions/allergies were reported. On unknown dates these unspecified patients were vaccinated with improperly stored ZOSTAVAX (strength, dosing details, anatomical location, lot# and expiration date were unknown). No patients reported adverse effects. No product quality complaint was reported. This is one of the several reports from the same reporter. Additional information has been requested.
Pt experienced chills the night of his vaccination. The next morning upon waking around 8 am, tried to stand and legs gave way (pt fell onto floor). Says he experienced weakness in the legs, no dizziness, headache, or nausea reported. Even up till today (12/8) pt reports weakness in legs when tries to stand, still experiencing chills. Pt also reports vomiting on 12/7 as well.